AERx iDMS pulmonary insulin: Phase III data

By WIR Staff | May 3, 2004 | 7:00 AM GMT

Interim 12-month results from a Phase III trial of AERx iDMS pulmonary insulin showed delayed post-meal plasma glucose suppression in